Abilify and Metastases to lymph nodes - a phase IV clinical study of FDA data

Summary:

Metastases to lymph nodes is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are female, 50-59 old, also take Ambien, and have Metastases to bone.

The phase IV clinical study analyzes which people have Metastases to lymph nodes when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Metastases to lymph nodes?

Metastases to lymph nodes (cancer spreads to lymph node) is found to be associated with 671 drugs and 788 conditions by eHealthMe. Check the latest studies of Metastases to lymph nodes.

On Jul, 17, 2026

97,308 people reported to have side effects when taking Abilify.
Among them, 16 people (0.02%) have Metastases to lymph nodes.

Could Abilify cause Metastases to lymph nodes?

Among these 16 people:

What is the gender of people who have Metastases to lymph nodes when taking Abilify? *

female: 78.57 %
male: 21.43 %

What is the age of people who have Metastases to lymph nodes when taking Abilify? *

What are other drugs people take besides Abilify? *

What are other side effects people have besides Metastases to lymph nodes? *

Urinary Tract Infection: 11 people, 68.75%
Dyspnea (difficult or laboured breathing): 10 people, 62.50%
Stress And Anxiety: 10 people, 62.50%
Impaired Healing: 10 people, 62.50%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 10 people, 62.50%
Pain: 10 people, 62.50%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 10 people, 62.50%
Osteonecrosis Of Jaw (death of bone of jaw): 10 people, 62.50%
Injury: 10 people, 62.50%
Dental Caries: 10 people, 62.50%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 10 people, 62.50%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 8 people, 50.00%
Breast Cancer Metastatic: 3 people, 18.75%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 12.50%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 12.50%
Parkinson's Disease: 2 people, 12.50%
Paget's Disease (disorder that involves abnormal bone destruction and regrowth, which results in deformity): 2 people, 12.50%
Osteoporosis (bones weak and more likely to break): 2 people, 12.50%
Insomnia (sleeplessness): 2 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and have Metastases to lymph nodes?

- Check whether Metastases to lymph nodes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abilify:

Abilify (101,454 reports)

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Metastases to lymph nodes:

Metastases to lymph nodes (671 drugs)

Browse all the conditions that are associated with Metastases to lymph nodes:

Metastases to lymph nodes (788 conditions)

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.